An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.
Tilorone has been studied across 19 research domains including 🛡️ Immunity, 🔬 Oncology, 🫁 Liver & Detox, 🔬 Inflammation, 🫘 Kidney. The primary research focus is 🛡️ Immunity with 37% of studies addressing this area.
The following compounds share molecular targets with Tilorone, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Tilorone is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.